-
1
-
-
0020403095
-
In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes
-
7175438 10.1084/jem.156.6.1604 1:STN:280:DyaL3s%2FosVGksg%3D%3D
-
Burger EH, Van der Meer JW, van de Gevel JS, Gribnau JC, Thesingh GW, van Furth R (1982) In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes. J Exp Med 156:1604-1614
-
(1982)
J Exp Med
, vol.156
, pp. 1604-1614
-
-
Burger, E.H.1
Van Der Meer, J.W.2
Van De Gevel, J.S.3
Gribnau, J.C.4
Thesingh, G.W.5
Van Furth, R.6
-
2
-
-
0037673945
-
Osteoclast differentiation and activation
-
12748652 10.1038/nature01658 1:CAS:528:DC%2BD3sXjs1ynu7g%3D
-
Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337-342
-
(2003)
Nature
, vol.423
, pp. 337-342
-
-
Boyle, W.J.1
Simonet, W.S.2
Lacey, D.L.3
-
3
-
-
78651010566
-
Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin)
-
18860765 10.1056/NEJM194806032382301 1:CAS:528:DyaH1cXjt1Chtg%3D%3D
-
Farber S, Diamond LK, Mercer RD, Sylvester RF, Wolff JA (1948) Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin). N Engl J Med 238:787-793
-
(1948)
N Engl J Med
, vol.238
, pp. 787-793
-
-
Farber, S.1
Diamond, L.K.2
Mercer, R.D.3
Sylvester, R.F.4
Wolff, J.A.5
-
4
-
-
0021923633
-
Efficacy of low-dose methotrexate in rheumatoid arthritis
-
3883172 10.1056/NEJM198503283121303 1:STN:280:DyaL2M7jslOmtw%3D%3D
-
Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, Glass DN, Trentham DE (1985) Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 312:818-822
-
(1985)
N Engl J Med
, vol.312
, pp. 818-822
-
-
Weinblatt, M.E.1
Coblyn, J.S.2
Fox, D.A.3
Fraser, P.A.4
Holdsworth, D.E.5
Glass, D.N.6
Trentham, D.E.7
-
5
-
-
0016756272
-
Continuous cultures of fused cells secreting antibody of predefined specificity
-
1172191 10.1038/256495a0
-
Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497
-
(1975)
Nature
, vol.256
, pp. 495-497
-
-
Köhler, G.1
Milstein, C.2
-
6
-
-
0017135663
-
Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion
-
825377 10.1002/eji.1830060713
-
Köhler G, Milstein C (1976) Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol 6:511-519
-
(1976)
Eur J Immunol
, vol.6
, pp. 511-519
-
-
Köhler, G.1
Milstein, C.2
-
7
-
-
0028073811
-
Novel cell-surface Ag expressed on rat osteoclasts regulating the function of the calcitonin receptor
-
7963580 1:CAS:528:DyaK2MXit1Gjtr4%3D
-
Kukita T, Kukita A, Nagata K, Maeda H, Kurisu K, Watanabe T, Iijima T (1994) Novel cell-surface Ag expressed on rat osteoclasts regulating the function of the calcitonin receptor. J Immunol 153:5265-5273
-
(1994)
J Immunol
, vol.153
, pp. 5265-5273
-
-
Kukita, T.1
Kukita, A.2
Nagata, K.3
Maeda, H.4
Kurisu, K.5
Watanabe, T.6
Iijima, T.7
-
8
-
-
0030061202
-
Osteoclast differentiation antigen
-
8839769 1:STN:280:DyaK28vjs12msQ%3D%3D
-
Kukita T, Kukita A (1996) Osteoclast differentiation antigen. Histol Histopathol 11:821-830
-
(1996)
Histol Histopathol
, vol.11
, pp. 821-830
-
-
Kukita, T.1
Kukita, A.2
-
9
-
-
0031824662
-
Successful detection of active osteoclasts in situ by systemic administration of an osteoclast-specific monoclonal antibody
-
9685521 10.1007/s002239900506 1:CAS:528:DyaK1cXkvFWlsrg%3D
-
Kukita T, Kukita A, Xu L, Maeda H, Iijima T (1998) Successful detection of active osteoclasts in situ by systemic administration of an osteoclast-specific monoclonal antibody. Calcif Tissue Int 63:148-153
-
(1998)
Calcif Tissue Int
, vol.63
, pp. 148-153
-
-
Kukita, T.1
Kukita, A.2
Xu, L.3
Maeda, H.4
Iijima, T.5
-
10
-
-
0034922665
-
Osteoclast differentiation antigen, distinct from receptor activator of nuclear factor kappa B, is involved in osteoclastogenesis under calcitonin-regulated conditions
-
11431150 10.1677/joe.0.1700175 1:CAS:528:DC%2BD3MXltlaks78%3D
-
Kukita T, Kukita A, Watanabe T, Iijima T (2001) Osteoclast differentiation antigen, distinct from receptor activator of nuclear factor kappa B, is involved in osteoclastogenesis under calcitonin-regulated conditions. J Endocrinol 170:175-183
-
(2001)
J Endocrinol
, vol.170
, pp. 175-183
-
-
Kukita, T.1
Kukita, A.2
Watanabe, T.3
Iijima, T.4
-
11
-
-
0027788057
-
Heat-treated osteoblastic cell (ROS17/2.8)-conditioned medium induces the formation of osteoclast-like cells
-
8305877 10.1016/S0169-6009(08)80048-7 1:CAS:528:DyaK2cXhvVerurs%3D
-
Kukita A, Kukita T, Hata K, Kurisu K, Kohashi O (1993) Heat-treated osteoblastic cell (ROS17/2.8)-conditioned medium induces the formation of osteoclast-like cells. Bone Miner 23:113-127
-
(1993)
Bone Miner
, vol.23
, pp. 113-127
-
-
Kukita, A.1
Kukita, T.2
Hata, K.3
Kurisu, K.4
Kohashi, O.5
-
12
-
-
0027373049
-
Induction of mononuclear precursor cells with osteoclastic phenotypes in a rat bone marrow culture system depleted of stromal cells
-
8250894 10.1006/bbrc.1993.2406 1:CAS:528:DyaK2cXls1ym
-
Kukita A, Kukita T, Shin JH, Kohashi O (1993) Induction of mononuclear precursor cells with osteoclastic phenotypes in a rat bone marrow culture system depleted of stromal cells. Biochem Biophys Res Commun 196:1383-1389
-
(1993)
Biochem Biophys Res Commun
, vol.196
, pp. 1383-1389
-
-
Kukita, A.1
Kukita, T.2
Shin, J.H.3
Kohashi, O.4
-
13
-
-
79955548681
-
Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis
-
21339747 10.1038/labinvest.2011.9 1:CAS:528:DC%2BC3MXlt1Gks70%3D
-
Teramachi J, Kukita A, Li Y-J, Ushijima Y, Ohkuma H, Wada N, Watanabe T, Nakamura S, Kukita T (2011) Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis. Lab Invest 91:719-731
-
(2011)
Lab Invest
, vol.91
, pp. 719-731
-
-
Teramachi, J.1
Kukita, A.2
Li, Y.-J.3
Ushijima, Y.4
Ohkuma, H.5
Wada, N.6
Watanabe, T.7
Nakamura, S.8
Kukita, T.9
-
14
-
-
34247592459
-
Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritis
-
17278017 10.1007/s10165-006-0531-1 1:CAS:528:DC%2BD2sXht1ygur8%3D
-
Suematsu A, Tajiri Y, Nakashima T, Taka J, Ochi S, Oda H, Nakamura K, Tanaka S, Takayanagi H (2007) Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritis. Mod Rheumatol 17:17-23
-
(2007)
Mod Rheumatol
, vol.17
, pp. 17-23
-
-
Suematsu, A.1
Tajiri, Y.2
Nakashima, T.3
Taka, J.4
Ochi, S.5
Oda, H.6
Nakamura, K.7
Tanaka, S.8
Takayanagi, H.9
-
15
-
-
10444273254
-
Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand
-
15593184 10.1002/art.20637 1:CAS:528:DC%2BD2MXls1ehuw%3D%3D
-
Lee CK, Lee EY, Chung SM, Mun SH, Yoo B, Moon HB (2004) Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand. Arthritis Rheum 50:3831-3843
-
(2004)
Arthritis Rheum
, vol.50
, pp. 3831-3843
-
-
Lee, C.K.1
Lee, E.Y.2
Chung, S.M.3
Mun, S.H.4
Yoo, B.5
Moon, H.B.6
-
16
-
-
77954447976
-
Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function
-
20181934 10.1096/fj.09-147447 1:CAS:528:DC%2BC3cXptV2ktb0%3D
-
Kara FM, Chitu V, Sloane J, Axelrod M, Fredholm BB, Stanley ER, Cronstein BN (2010) Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function. FASEB J 24:2325-2333
-
(2010)
FASEB J
, vol.24
, pp. 2325-2333
-
-
Kara, F.M.1
Chitu, V.2
Sloane, J.3
Axelrod, M.4
Fredholm, B.B.5
Stanley, E.R.6
Cronstein, B.N.7
|